Variation in plasma RNA levels, CD4 cell counts, and p24 antigen levels in clinically stable men with human immunodeficiency virus infection

Journal of Infectious Diseases

Volumn 174, Issue 1, 1996, Pages 191-194

  Raboud, J M ^a   Montaner, J S G ^b   Conway, B ^b   Haley, L ^b   Sherlock, C ^b   O'Shaughnessy, M V ^b   Schechter, M T ^b  

^a Canadian HIV Trials Network   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; RNA POLYMERASE;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; DISEASE ASSOCIATION; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE COMPLEX DISEASE; LYMPHOCYTE COUNT; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RELIABILITY;

EID: 0030055871     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/174.1.191     Document Type: Article

References (12)

1. Montaner JSG, Wainberg M, Rachlis A, et al. A double blind comparative trial of didanosine versus continued zidovudine therapy for moderately advanced human immunodeficiency virus infection. Ann Intern Med 1995;123:561-71.
2. Concorde Coordinating Committee. Concorde: MRC/ANRS randomised double-blind controlled trial comparing immediate and deferred zidovudine in asymptomatic HIV infection. Lancet 1994;343:871-81.
3. Coffin JM. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 1995;267:483-9.
4. Raboud JM, Haley L, Montaner JSG, Murphy C, Januszewska M, Schechter MT. Quantification of the variation due to laboratory and physiologic sources in CD4 lymphocyte counts of clinically stable HIV infected individuals. J Acquir Immune Defic Syndr 1995;10:S67-73.
5. + T cell determinations in persons with human immunodeficiency virus infection. MMWR Morb Mortal Wkly Rep 1992;41:1-17.
6. Streiner DL, Norman GR. Health measurement scales. Oxford, UK: Oxford University Press, 1989.
7. Semple M, Loveday C, Weller I, Tedder R. Direct measurement of viraemia in patients infected with HIV-1 and its relationship to disease progression and zidovudine therapy. J Med Virol 1991;35:38-45.
8. Holodniy M, Mole L, Winters M, Merigan TC. Diurnal and short-term stability of HIV virus load as measured by gene amplification. J Acquir Immune Defic Syndr 1994;7:363-8.
9. Winters MA, Tan LB, Katzenstein DA, Merigan TC. Biological variation and quality control of plasma human immunodeficiency virus type 1 RNA quantitation by reverse transcriptase polymerase chain reaction. J Clin Microbiol 1993;31:2960-6.
10. Yerly S, Chamot E, Hirschel B, Perrin LH. Quantitation of human immuno-deficiency virus provirus and circulating virus: relationship with immunologic parameters. J Infect Dis 1992;166:269-76.
11. Aoki-Sei SR, Yarchoan R, Kageyama S, et al. Plasma HIV-1 viremia in HIV-1 infected individuals assessed by polymerase chain reaction. AIDS Res Hum Retroviruses 1992;8:1263-70.
12. Pantaleo G, Menzo S, Vaccrezza M, et al. Studies in subjects with long-term non-progressive human immunodeficiency virus infection. N Engl J Med 1995;332:209-16.